ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Weight Control Drug Lorcaserin May Raise Cancer Risk
January 16, 2020The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration says. -
FDA issues alert for cancer risk from Belviq (lorcaserin)
January 16, 2020The US FDA has announced a warning to healthcare professionals and patients that the weight management drug Belviq may be a cause of cancer. -
Study shows Eisai's obesity drug Belviq does not increase major cardiovascular events
August 29, 2018Study results presented at the European Society of Cardiology (ESC) congress showed that in a high-risk population of overweight or obese patients, Eisai's Belviq (lorcaserin) was associated with sustained weight loss without a higher rate of major cardio
Pharma Sources Insight January 2025
